PTC Therapeutics, Inc. Increase (Decrease) in Inventories
PTC Therapeutics, Inc. (PTCT) reported Increase (Decrease) in Inventories of $13.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-30
- PTC Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $15.86M, a 47.10% increase year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$2.64M.
- PTC Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $26.78M.
- PTC Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $18.53M, a 496.46% increase year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in inventories for fiscal 2025 was $53.90M.
- PTC Therapeutics, Inc. increase (decrease) in inventories for fiscal 2024 was -$6.16M, a 175.33% decline from fiscal 2023.
- PTC Therapeutics, Inc. increase (decrease) in inventories for fiscal 2023 was $8.18M, a 22.72% increase from fiscal 2022.
- PTC Therapeutics, Inc. increase (decrease) in inventories for fiscal 2022 was $6.67M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $13.22M 10-Q · filed 2026-07-30 | $40.00M derived: sum of 3 quarters · filed 2026-07-30 | $58.52M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$2.64M 10-Q · filed 2026-05-07 | $24.14M derived: sum of 2 quarters · filed 2026-05-07 | $42.66M derived: sum of 3 quarters · filed 2026-05-07 | $53.44M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $26.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $45.30M derived: sum of 2 quarters · filed 2026-02-19 | $56.09M derived: sum of 3 quarters · filed 2026-07-30 | $53.90M 10-K · filed 2026-02-19 |
| 2025-09-30 | $18.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $29.31M derived: sum of 2 quarters · filed 2026-07-30 | $27.12M 10-Q · filed 2025-11-04 | $16.03M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $10.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $8.59M 10-Q · filed 2026-07-30 | -$2.50M derived: sum of 3 quarters · filed 2026-07-30 | $611.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$2.19M 10-Q · filed 2026-05-07 | -$13.28M derived: sum of 2 quarters · filed 2026-05-07 | -$10.17M derived: sum of 3 quarters · filed 2026-05-07 | -$8.23M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$11.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$7.98M derived: sum of 2 quarters · filed 2026-02-19 | -$6.04M derived: sum of 3 quarters · filed 2026-02-19 | -$6.16M 10-K · filed 2026-02-19 |
| 2024-09-30 | $3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.04M derived: sum of 2 quarters · filed 2025-11-04 | $4.92M 10-Q · filed 2025-11-04 | -$1.02M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.82M 10-Q · filed 2025-08-07 | -$4.12M derived: sum of 3 quarters · filed 2026-02-19 | $204.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$120.00K 10-Q · filed 2025-05-06 | -$6.06M derived: sum of 2 quarters · filed 2026-02-19 | -$1.73M derived: sum of 3 quarters · filed 2026-02-19 | $3.45M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$5.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$1.61M derived: sum of 2 quarters · filed 2026-02-19 | $3.57M derived: sum of 3 quarters · filed 2026-02-19 | $8.18M 10-K · filed 2026-02-19 |
| 2023-09-30 | $4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $9.51M derived: sum of 2 quarters · filed 2024-11-07 | $14.12M 10-Q · filed 2024-11-07 | $20.02M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $9.79M 10-Q · filed 2024-08-08 | $15.70M derived: sum of 3 quarters · filed 2025-02-27 | $16.49M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $4.61M 10-Q · filed 2024-04-25 | $10.51M derived: sum of 2 quarters · filed 2025-02-27 | $11.31M derived: sum of 3 quarters · filed 2025-02-27 | $11.63M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.70M derived: sum of 2 quarters · filed 2025-02-27 | $7.02M derived: sum of 3 quarters · filed 2025-02-27 | $6.67M 10-K · filed 2025-02-27 |
| 2022-09-30 | $795.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $1.12M derived: sum of 2 quarters · filed 2023-10-26 | $768.00K 10-Q · filed 2023-10-26 | $1.44M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $323.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$27.00K 10-Q · filed 2023-08-03 | $649.00K derived: sum of 3 quarters · filed 2024-02-29 | $79.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$350.00K 10-Q · filed 2023-04-27 | $326.00K derived: sum of 2 quarters · filed 2024-02-29 | -$244.00K derived: sum of 3 quarters · filed 2024-02-29 | -$187.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $106.00K derived: sum of 2 quarters · filed 2024-02-29 | $163.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.80M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$570.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$513.00K derived: sum of 2 quarters · filed 2022-10-27 | -$2.48M 10-Q · filed 2022-10-27 | -$3.93M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.91M 10-Q · filed 2022-08-04 | -$3.36M derived: sum of 3 quarters · filed 2023-02-21 | -$2.80M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | -$1.96M 10-Q · filed 2022-05-03 | -$3.41M derived: sum of 2 quarters · filed 2023-02-21 | -$2.86M derived: sum of 3 quarters · filed 2023-02-21 | -$3.70M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$898.00K derived: sum of 2 quarters · filed 2023-02-21 | -$1.74M derived: sum of 3 quarters · filed 2023-02-21 | -$1.84M 10-K · filed 2023-02-21 |
| 2020-09-30 | $553.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$288.00K derived: sum of 2 quarters · filed 2021-10-28 | -$390.00K 10-Q · filed 2021-10-28 | $1.49M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$841.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$943.00K 10-Q · filed 2021-07-29 | $939.00K derived: sum of 3 quarters · filed 2022-02-22 | $1.66M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | -$102.00K 10-Q · filed 2021-05-04 | $1.78M derived: sum of 2 quarters · filed 2022-02-22 | $2.50M derived: sum of 3 quarters · filed 2022-02-22 | $3.02M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $2.60M derived: sum of 2 quarters · filed 2022-02-22 | $3.12M derived: sum of 3 quarters · filed 2022-02-22 | $3.46M 10-K · filed 2022-02-22 |
| 2019-09-30 | $722.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.24M derived: sum of 2 quarters · filed 2020-10-29 | $1.57M 10-Q · filed 2020-10-29 | $4.14M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $518.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $852.00K 10-Q · filed 2020-08-05 | $3.42M derived: sum of 3 quarters · filed 2021-02-25 | $3.28M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $334.00K 10-Q · filed 2020-04-30 | $2.90M derived: sum of 2 quarters · filed 2021-02-25 | $2.76M derived: sum of 3 quarters · filed 2021-02-25 | $4.71M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.43M derived: sum of 2 quarters · filed 2021-02-25 | $4.38M derived: sum of 3 quarters · filed 2021-02-25 | $5.82M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $1.81M derived: sum of 2 quarters · filed 2019-10-30 | $3.25M 10-Q · filed 2019-10-30 | $6.08M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.39M 10-Q · filed 2019-08-06 | $6.22M derived: sum of 3 quarters · filed 2020-03-02 | $7.04M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $1.45M 10-Q · filed 2019-05-02 | $4.28M derived: sum of 2 quarters · filed 2020-03-02 | $5.09M derived: sum of 3 quarters · filed 2020-03-02 | $6.55M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.65M derived: sum of 2 quarters · filed 2020-03-02 | $5.10M derived: sum of 3 quarters · filed 2020-03-02 | $6.45M 10-K · filed 2020-03-02 |
| 2017-09-30 | $819.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $2.27M derived: sum of 2 quarters · filed 2018-11-05 | $3.63M 10-Q · filed 2018-11-05 | $3.63M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.81M 10-Q · filed 2018-08-07 | $2.81M derived: sum of 3 quarters · filed 2019-03-01 | $2.81M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $1.35M 10-Q · filed 2018-05-09 | $1.35M derived: sum of 2 quarters · filed 2019-03-01 | $1.35M derived: sum of 3 quarters · filed 2019-03-01 | $1.35M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |